2022
Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Lohmeier, J., Silva, R.V., Tietze, A., Taupitz, M., Kaneko, T., Prüss, H., Paul, F., Infante-Duarte, C., Hamm, B., Caravan, P. and Makowski, M.R.
European Journal of Nuclear Medicine and Molecular Imaging 49
(11): 3692–3704.
September 2022
2011
Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data.
Schulz, V., Torres-Espallardo, I., Renisch, S., Hu, Z.B., Ojha, N., Boernert, P., Perkuhn, M., Niendorf, T., Schaefer, W.M., Brockmann, H., Krohn, T., Buhl, A., Guenther, R.W., Mottaghy, F.M. and Krombach, G.A.
European Journal of Nuclear Medicine and Molecular Imaging 38
(1): 138-152.
January 2011
2005
Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience.
Bienert, M., Reisinger, I., Srock, S., Humplik, B.I., Reim, C., Kroessin, T., Avril, N., Pezzutto, A. and Munz, D.L.
European Journal of Nuclear Medicine and Molecular Imaging 32
: 1225-1233.
1 January 2005
2004
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
Amthauer, H., Denecke, T., Rau, B., Hildebrandt, B., Huenerbein, M., Ruf, J., Schneider, U., Gutberlet, M., Schlag, P.M., Felix, R. and Wust, P.
European Journal of Nuclear Medicine and Molecular Imaging 31
(6): 811-819.
1 January 2004
This list was generated on Thu Oct 3 10:03:12 2024 UTC.